Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01207934 · ClinicalTrials.gov registry record · NA
Recombinant Human Leptin Therapy Effects on Insulin Action
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01207934 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 18 participants.
The verdict
NCT01207934, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Leptin therapy improves insulin sensitivity in people with leptin-deficiency but it is not known whether it improves insulin action in persons who are not leptin deficient. The purpose of the present study was to determine whether leptin therapy has effects on insulin action in obese subjects with type 2 diabetes mellitus (T2DM). A randomized, placebo controlled trial was conducted in obese subjects with newly-diagnosed T2DM. Subjects were randomized to treatment with placebo, low-dose, or high-dose leptin. Insulin sensitivity was measured.
Interventions
- DIETARY_SUPPLEMENT placebo
- DRUG low-dose leptin
- DRUG high-dose leptin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 1998-08 |
| Est. Completion | 2000-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01207934
The ClinicalTrials.gov registry entry for NCT01207934 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT01207934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01207934 about?
NCT01207934 is a clinical study titled "Recombinant Human Leptin Therapy Effects on Insulin Action". Leptin therapy improves insulin sensitivity in people with leptin-deficiency but it is not known whether it improves insulin action in persons who are not leptin deficient. The purpose of the present study was to determine whether leptin therapy has effects on insulin action in obese subjects with t...
What is the current status of trial NCT01207934?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 1998-08. Estimated completion is 2000-07.
What interventions are being tested in trial NCT01207934?
The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), low-dose leptin (DRUG), high-dose leptin (DRUG).
Who is sponsoring clinical trial NCT01207934?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.